Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This issue explores the latest choices in HIV regimens for various groups, including youth and older people.
Here are considerations for long-term survivors thinking about switching HIV treatments.
Under 30? Here’s what to consider if you’re thinking about switching HIV treatments.
Switching to a long-acting injectable was right on time for these three people living with HIV.
Injections of cabotegravir given once every two months may work even better than daily pills for HIV prevention.
People who used long-acting Cabenuva preferred the injections over their previous daily oral regimen.
Switching HIV treatments from a daily pill to a monthly injectable has given Mike Hellman more freedom outdoors.
From daily pills to long-acting injectables, there are many HIV regimens to consider.
Selecting an HIV regimen depends on doing your homework.
Injections given every month or every other month were preferred over daily pills.
Shirley Selvage has built a healthy partnership with her providers.
Advice from a physician on building a partnership with your providers.
Getting the most from your health care team is up to you.
The updates include new information on optimizing therapy, dealing with virological failure and managing opportunistic infections.
Switching HIV regimens from a daily oral pill to a monthly injectable has given Alex Vance more headspace.
Study finds that Cabenuva administered every other month maintains viral suppression for two years.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.